CLINICAL_TRIALS
trial_result
· 2020-06-17
Clinical Trial Update: Compare Safety and Efficacy of BIBF 1120 Versus Sunitinib. [Phase 2]
Summary
Phase 2 trial comparing BIBF 1120 with sunitinib in renal cell carcinoma completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Carcinoma, Renal Cell | Phase 2 | Status: COMPLETED | Results posted: 2020-06-17